Concepedia

Melissa T. Bu

MT

Statistics

Publications

4

Citations

131

H-Index

4

Active since

2021

Affiliations

Dana-Farber Cancer Institute(Current)

Parker Institute for Cancer Immunotherapy

University of California, Los Angeles

Melissa T. Bu is an author at Dana-Farber Cancer Institute specializing in cancer immunology, cancer immunotherapy, and oncology.

ORCID

Publications per year

2021–2024

4

Publications

4

TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial

Richard G. Everson, Willy Hugo, Lu Sun et al. · Nature Communications · 2024 · 63 citations · Full text

, , +17

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

Lizhong Ding, Lu Sun, Melissa T. Bu et al. · Frontiers in Immunology · 2023 · 24 citations · Full text

, , +17

A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies

Melissa T. Bu, Long Yuan, Alyssa N. Klee et al. · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · 2022 · 23 citations · Full text

, , +17

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

Xia Bu, Vikram R. Juneja, Carol Reynolds et al. · Cancer Immunology Research · 2021 · 21 citations · Full text

, , +17

1–4 of 4